Clinical trial Recruiting at 1 site Observational Ages 40 to 70 Women only

Lysyl Enzymes in Knee Osteoarthritis

Official title: Lysyl Oxidase and Lysyl Hydroxylase Levels in Patients With Knee Osteoarthritis

Run by Afyonkarahisar Health Sciences University · NCT07875296 · Data updated 2026-11-12

This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.

Quick facts

Study typeObservational
Ages40 Years to 70 Years
SexWomen only
Enrollment200 (estimated)
SponsorAfyonkarahisar Health Sciences University
Academic / other
Locations1 site (Afyonkarahisar)
StatusRecruiting
StartedMay 5, 2025
Main results expectedJanuary 3, 2027
Study endsApril 3, 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07875296 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 40–70 with clinically and radiographically diagnosed knee OA, within BMI 18.5–40 kg/m², without major comorbidities.

Probably not a fit

Patients with significant comorbidities or non-OA knee conditions may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will measure serum levels of lysyl hydroxylase, lysyl oxidase, and related LOX family enzymes in adults with knee OA at different stages and compare them to healthy controls. It will focus on how these enzymes relate to joint degeneration and ECM cross-linking in the cartilage. Participants are female, 40–70 years old, with knee OA, recruited from Afyonkarahisar Health Sciences University, with BMI 18.5–40 kg/m². The study will exclude those with major comorbidities or inflammatory rheumatic diseases. No interventions are administered; samples and data are collected to explore potential biomarkers and disease mechanisms.

Why it matters

Potential benefit: If successful, findings could identify biomarkers that reflect cartilage remodeling and disease progression in knee OA.

How similar studies have gone: Similar work has begun to explore LOX family enzymes in OA, but this study adds a focused biomarker comparison with healthy controls.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female participants aged between 40 and 70 years.
* Diagnosed with knee osteoarthritis according to clinical and radiographic criteria, and presenting to the Department of Physical Medicine and Rehabilitation, Afyonkarahisar Health Sciences University (AFSU).
* Body Mass Index (BMI) between 18.5 and 40 kg/m².

Exclusion Criteria:

* Presence of metabolic diseases or severe comorbidities, including uncontrolled diabetes mellitus, chronic kidney disease (GFR \< 60 mL/min/1.73 m²), liver failure, malignancy, severe cardiovascular disease, chronic respiratory disorders, or chronic intestinal diseases.
* Any inflammatory arthritis or other rheumatologic disease with related signs or symptoms.
* History of knee trauma involving cruciate ligaments or menisci within the past 3 months.
* Secondary osteoarthritis due to other joint disorders such as septic arthritis, avascular necrosis, or Paget's disease.
* History of previous knee surgery.
* Recent intra-articular injection to the knee joint within the last 3 months.

Where it's running

  • Afyonkarahisar Health Sciences University, Department of Physical Medicine and Rehabilitation
    Afyonkarahisar, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Hasan Toktaş, Professor — Afyonkarahisar Health Sciences University
  • Study coordinator: Hasan Toktaş, Professor
  • Email: hasantoktas@yahoo.com
  • Phone: +905052212901

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.